Mr Addison has been involved in high quality basic-science and clinical research throughout his training and career.
As a medical student at Cambridge University, he obtained a First Class degree, one third of which was awarded for his original laboratory research project in Pharmacology. As a trainee in eye surgery, Mr Addison completed clinical research projects in ocular oncology
at St Bartholomew’s Hospital, London and in cataract surgery
at The Cambridge University Teaching Hospitals. During two years of full-time clinical and laboratory research on the
molecular genetics of inherited human cataract
at the UCL Institute of Ophthalmology, Mr Addison discovered and published papers on novel molecular genetic causes of inherited cataracts. He was awarded his Doctorate of Medicine degree after completing his thesis, which is accessible via The British Library.
As a Consultant, Mr Addison has continued to be actively involved in research, with a special interest in novel therapies to treat Medical Retinal and Uveitis disorders. He aims to ensure that his patients have access to the very latest cutting-edge therapies for their conditions, which he can deliver to them as soon as there is clinical evidence to support their use, often having been closely involved in generating that evidence or trialling those treatments in local, national and international studies. Since 2012, Mr Addison has been a co-investigator on 12 different international clinical trials
including those investigating novel therapies for wet and dry age-related macular degeneration, retinal vein occlusion, uveitis and novel gene therapy for inherited eye disease. He is currently the principal investigator for a national study on the genetics of steroid induced intra-ocular pressure rise.
Previously, he was principal investigator for an international randomised controlled trial on central retinal vein occlusion.
Please find below a list of Mr Addison's publications and presentations: